Latest BML Capital Management, LLC Stock Portfolio
BML Capital Management, LLC Performance:
2024 Q3: 12.8%YTD: 5.76%2023: -2.64%
Performance for 2024 Q3 is 12.8%, and YTD is 5.76%, and 2023 is -2.64%.
About BML Capital Management, LLC and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, BML Capital Management, LLC reported an equity portfolio of $169.9 Millions as of 30 Sep, 2024.
The top stock holdings of BML Capital Management, LLC are DMXF, TIL, AVIR. The fund has invested 16% of it's portfolio in ISHARES TR and 13.3% of portfolio in INSTIL BIO INC.
The fund managers got completely rid off ATHIRA PHARMA INC (ATHA), DESIGN THERAPEUTICS INC (DSGN) and FORTE BIOSCIENCES INC (FBRX) stocks. They significantly reduced their stock positions in TECTONIC THERAPEUTIC INC, VANDA PHARMACEUTICALS INC (VNDA) and INSTIL BIO INC (TIL). BML Capital Management, LLC opened new stock positions in AN2 THERAPEUTICS INC (ANTX), AADI BIOSCIENCE INC (AADI) and PIERIS PHARMACEUTICALS INC (PIRS). The fund showed a lot of confidence in some stocks as they added substantially to ACHILLES THERAPEUTICS PLC (ACHL), TALIS BIOMEDICAL CORP (TLIS) and ORAMED PHARMACEUTICALS INC (ORMP).
The top stock holdings of BML Capital Management, LLC are DMXF, TIL, AVIR. The fund has invested 16% of it's portfolio in ISHARES TR and 13.3% of portfolio in INSTIL BIO INC.
The fund managers got completely rid off ATHIRA PHARMA INC (ATHA), DESIGN THERAPEUTICS INC (DSGN) and FORTE BIOSCIENCES INC (FBRX) stocks. They significantly reduced their stock positions in TECTONIC THERAPEUTIC INC, VANDA PHARMACEUTICALS INC (VNDA) and INSTIL BIO INC (TIL). BML Capital Management, LLC opened new stock positions in AN2 THERAPEUTICS INC (ANTX), AADI BIOSCIENCE INC (AADI) and PIERIS PHARMACEUTICALS INC (PIRS). The fund showed a lot of confidence in some stocks as they added substantially to ACHILLES THERAPEUTICS PLC (ACHL), TALIS BIOMEDICAL CORP (TLIS) and ORAMED PHARMACEUTICALS INC (ORMP).
BML Capital Management, LLC Annual Return Estimates Vs S&P 500
Our best estimate is that BML Capital Management, LLC made a return of 12.8% in the last quarter. In trailing 12 months, it's portfolio return was -2.69%.
New Buys
| Ticker | $ Bought |
|---|---|
| an2 therapeutics inc | 6,151,890 |
| aadi bioscience inc | 4,120,000 |
| pieris pharmaceuticals inc | 698,515 |
| forte biosciences inc | 393,916 |
| hillevax inc | 34,778 |
New stocks bought by BML Capital Management, LLC
Additions
| Ticker | % Inc. |
|---|---|
| achilles therapeutics plc | 555 |
| talis biomedical corp | 481 |
| oramed pharmaceuticals inc | 62.06 |
| reneo pharmaceuticals inc | 29.38 |
| pmv pharmaceuticals inc | 28.97 |
| ikena oncology inc | 23.61 |
| adverum biotechnologies inc | 15.36 |
| aclaris therapeutics inc | 9.72 |
Additions to existing portfolio by BML Capital Management, LLC
Reductions
| Ticker | % Reduced |
|---|---|
| tectonic therapeutic inc | -54.56 |
| vanda pharmaceuticals inc | -42.63 |
| instil bio inc | -14.34 |
| spdr ser tr | -12.5 |
| lenz therapeutics inc | -6.13 |
| calcimedica inc | -4.07 |
BML Capital Management, LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| forte biosciences inc | -946,034 |
| athira pharma inc | -2,385,000 |
| design therapeutics inc | -1,412,860 |
BML Capital Management, LLC got rid off the above stocks
Sector Distribution
BML Capital Management, LLC has about 63.5% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 63.5 |
| Others | 35 |
Market Cap. Distribution
BML Capital Management, LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| MICRO-CAP | 56.1 |
| UNALLOCATED | 35 |
| NANO-CAP | 8.3 |
Stocks belong to which Index?
About 31.9% of the stocks held by BML Capital Management, LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 68.1 |
| RUSSELL 2000 | 31.9 |
BML Capital Management, LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of BML Capital Management, LLC
BML Capital Management, LLC has 29 stocks in it's portfolio. About 84.8% of the portfolio is in top 10 stocks. VRCA proved to be the most loss making stock for the portfolio. TIL was the most profitable stock for BML Capital Management, LLC last quarter.
Last Reported on: 05 Nov, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| AADI | aadi bioscience inc | 2.42 | 2,000,000 | 4,120,000 | new | |||
| ACHL | achilles therapeutics plc | 2.46 | 4,100,000 | 4,182,000 | added | 555 | ||
| ACRS | aclaris therapeutics inc | 9.64 | 14,250,000 | 16,387,500 | added | 9.72 | ||
| ADVM | adverum biotechnologies inc | 9.37 | 2,268,060 | 15,921,800 | added | 15.36 | ||
| ALVR | allovir inc | 0.29 | 603,086 | 487,595 | unchanged | 0.00 | ||
| ANTX | an2 therapeutics inc | 3.62 | 5,749,430 | 6,151,890 | new | |||
| ASTC | astrotech corp | 1.04 | 220,410 | 1,761,080 | unchanged | 0.00 | ||
| ATHA | athira pharma inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| AVIR | atea pharmaceuticals inc | 13.11 | 6,650,000 | 22,277,500 | added | 4.3 | ||
| BIL | spdr ser tr | 9.45 | 175,000 | 16,066,800 | reduced | -12.5 | ||
| CLBS | lisata therapeutics inc | 0.50 | 284,669 | 854,007 | unchanged | 0.00 | ||
| CNTB | connect biopharma hldgs ltd | 1.77 | 2,093,230 | 3,014,040 | added | 2.45 | ||
| DMXF | ishares tr | 16.00 | 270,000 | 27,194,400 | unchanged | 0.00 | ||
| DSGN | design therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| FBRX | forte biosciences inc | 0.23 | 70,468 | 393,916 | new | |||
| FBRX | forte biosciences inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| HLVX | hillevax inc | 0.02 | 19,760 | 34,778 | new | |||
| IKNA | ikena oncology inc | 0.74 | 723,288 | 1,251,290 | added | 23.61 | ||
| MIST | milestone pharmaceuticals in | 1.02 | 1,136,090 | 1,726,860 | added | 3.01 | ||
| NXTC | nextcure inc | 0.22 | 276,465 | 378,757 | unchanged | 0.00 | ||